Lyra Therapeutics Inc
(NAS:LYRA)
$
0.1955
-0.0052 (-2.59%)
Market Cap: 12.80 Mil
Enterprise Value: -3.50 Mil
PE Ratio: 0
PB Ratio: 0.62
GF Score: 35/100 Lyra Therapeutics Inc in Maria Palasis & Strong Leadership in HealthTech Transcript
Oct 08, 2020 / NTS GMT
Release Date Price:
$11.43
(+2.97%)
Joe Mullings
The Mullings Group Companies - Moderator
Joe Mullings from One60 Studios in Delray Beach, Florida. I am sitting this morning with Maria Palasis, who is the President and Chief Executive Officer of Lyra Therapeutics, and she's joining us from Boston. Thanks for taking part of this this morning.
Maria Palasis
Lyra Therapeutics, Inc. - President, CEO, Director
Thank you, Joe. It's my pleasure.
Joe Mullings
The Mullings Group Companies - Moderator
Yeah, and we're getting together around the AdvaMed Conference happening up in -- well, I want to say up in Canada or Boston, but virtual this year. So that's been a bit of a change for everybody.
Maria Palasis
Lyra Therapeutics, Inc. - President, CEO, Director
Yeah.
Joe Mullings
The Mullings Group Companies - Moderator
Lyra, you head up. Lyra Therapeutics, and recently you took that organization public in the very early days of the COVID pandemic up in Boston. And I had
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot